Redington Life Sciences News | Special Issue February 2021 | ||
In this issue: Dana Farber on cancer and Covid-19, slashing TB treatment time, sleepless nights in the hood, Emory on severe allergies, cannabis for birth control, simple test for T cell immunity on its way, I-O breakthrough in mesothelioma, Mayo on risk of high insulin during childhood, gut microbes may drive brain disorders, and more… | |||
 | Dana-Farber to hold a discussion for cancer patients and survivors about the Covid-19 vaccine Dana-Farber Cancer Institute is having a virtual discussion for cancer patients and survivors about the Covid-19 vaccine on January 27, 2021 at 5 p.m. EST. Physicians from Dana-Farber will discuss common concerns and questions cancer patients and survivors have about the vaccine. Full Details |
 | Physician-pharmacist collaboration may increase adherence to opioid addiction treatment NIH-supported pilot study found team-based approach may improve buprenorphine care. |
| Tonix Pharmaceuticals to Develop COVID-19 Skin Test (TNX-2100) to Measure SARS-CoV-2 Exposure and T Cell Immunity Pre-IND Meeting Written Response from FDA Provides Guidance on Product Development and Clinical Testing Protocol Intradermal Test is Designed to Measure SARS-CoV-2 Specific Delayed Type Hypersensitivity (DTH), the Classic Method of Measuring T Cell Immunity to Tuberculosis and Other Pathogens |
| High insulin levels during childhood a risk for mental health problems later in life, study suggests Researchers have shown that the link between physical and mental illness is closer than previously thought. Certain changes in physical health, which are detectable in childhood, are linked with the development of mental illness in adulthood. |
| NIH study suggests using cannabis while trying to conceive may reduce pregnancy chances |
 | Detecting Alzheimer’s Gets Easier with a Simple Blood Test New assays could reduce the need for costlier, more invasive brain scans and spinal fluid measures
|
 | TG Therapeutics Announces FDA Accelerated Approval of UKONIQ™ (umbralisib) |
 | NEW TB DRUG REGIMEN SLASHES TREATMENT TIME Feb. 1, 2021: Tuberculosis is an age-old respiratory scourge, with a new twist: growing resistance to multiple first- and second-line drugs. UF researchers and physicians report on using a novel treatment to slash treatment time — and cure — a patient with extensively drug-resistant TB.
|
 | Yale study finds link between GME funding and public health benefits Each year the U.S. government spends billions of dollars on graduate medical education (GME) at the nation’s hospitals to support postgraduate physician training. |
| Researchers use patients’ cells to test gene therapy for rare eye disease Approach could provide new path for difficult-to-treat forms of Leber congenital amaurosis. |
 | How gut microbes could drive brain disorders |
| Study links neighborhood conditions to adolescent sleep loss Insufficient sleep decreases brain wave activity associated with cognition. |
 | Immunotherapy breakthrough could help mesothelioma patients survive longer Scientists in Southampton have made a major breakthrough that could help patients with mesothelioma survive for longer. |
| NIH researchers identify new genetic disorder that affects brain, craniofacial skeleton Analysis of patients with rare condition uncovers key pathway for human development. |
| Glacial episodes of a freshwater Arctic Ocean covered by a thick ice shelf Following early hypotheses about the possible existence of Arctic ice shelves in the past the observation of specific erosional features as deep as 1,000 metres below the current sea level confirmed the presence of a thick layer of ice on the Lomonosov Ridge in the central Arctic Ocean and elsewhere. |
| Heart disease remains the number one killer of American women Cardiovascular disease remains the leading cause of morbidity and mortality of women in the U.S. Few young and minority women are aware of their risk factors
|
 | Low-dose aspirin may improve pregnancy chances for women with one or two prior miscarriages New research suggests low-dose aspirin therapy before conception and during early pregnancy may increase pregnancy chances and live births among women who have experienced one or two prior miscarriages. |
| Study shows sharp decline in cancer screenings and diagnoses during the first COVID-19 surge Focusing on the largest health care system in the Northeast, the study is among the first to document the pandemic’s impact on cancer screening and diagnosis. |
| Genetic analysis yields new insights into PTSD Attempts to identify the genetic causes of neuropsychiatric diseases such as post-traumatic stress disorder (PTSD) through large-scale genome-wide analyses have yielded thousands of potential links. |
| Mayo Clinic study indicates age has distinct influences on sex-related outcomes after heart attack Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks. |
 | Scientists have identified a group of drugs that may help stop a leading cause of vision loss after making an unexpected discovery that overturns a fundamental belief about DNA. |
 | In lab study, nanoparticle shows promising results for treating severe allergies UCLA scientists develop approach that enables immune system to tolerate allergens |
 | Acute itching in eczema patients linked to environmental allergens |
| Researchers use patients’ cells to test gene therapy for rare eye disease Approach could provide new path for difficult-to-treat forms of Leber congenital amaurosis. |
| Study finds new evidence of health threat from chemicals in marijuana and tobacco smoke |
 | Johns Hopkins scientist develops method to find toxic chemicals in drinking water Only 11 byproducts from water disinfection are currently regulated in drinking water, and environmental engineer Carsten Prasse says there's more that must be done |
Ph: 212 926-1733 Email: info@redingtoninc.com
